Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sheena Shiwlani"'
Autor:
Subhash Chander, Roopa Kumari, Hong Yu Wang, Yaqub Nadeem Mohammed, Om Parkash, Sindhu Lohana, FNU Sorath, Abhi Chand Lohana, FNU Sadarat, Sheena Shiwlani
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background & objective The Infectious Disease Society of America guidelines recommend vancomycin trough levels of 15–20 mg/L for severe methicillin-resistant Staphylococcus aureus. However, recent consensus guidelines of four infectious di
Externí odkaz:
https://doaj.org/article/463fe5e627f54e8bac22fd285bb2441c
Autor:
Subhash Chander, Roopa Kumari, Sindhu Luhana, Sheena Shiwlani, Om Parkash, FNU Sorath, Hong Yu Wang, Sam Tan, Zubair Rahaman, Yaqub Nadeem Mohammed, Abhi Chand Lohana, FNU Sakshi, Esha Vaish, FNU Sadarat
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Catheter ablation and antiarrhythmic drug therapy are utilized for rhythm control in atrial fibrillation (AF), but their comparative effectiveness, especially with contemporary treatment modalities, remains undefined. We conducted
Externí odkaz:
https://doaj.org/article/e7028715f7f449faac198aeb53707426
Autor:
Subhash Chander, Om Parkash, Sindhu Luhana, Abhi Chand Lohana, Fnu Sadarat, Fnu Sapna, Fnu Raja, Zubair Rahaman, Yaqub Nadeem Mohammed, Sheena Shiwlani, NFN Kiran, Hong Yu Wang, Sam Tan, Roopa Kumari
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-20 (2024)
Abstract Background & objective Despite their continued use, the effectiveness and safety of vasopressors in post-cardiac arrest patients remain controversial. This study examined the efficacy of various vasopressors in cardiac arrest patients in ter
Externí odkaz:
https://doaj.org/article/45d0bfd64e554cd6aba81ad008155f3f
Autor:
Jamila Begum Jabar Ali, Sheena Shiwlani, Ali Totonchian, Neeraj Makheja, Amber Rizwan, Aman Siddiqui, Daniya Muhammad Haroon, Ishtiaq Ahmad, Jai Kumar
Publikováno v:
Cureus
Introduction: Oral methotrexate (MTX) is the first-line therapy for patients with rheumatoid arthritis (RA). However, not all RA patients respond to MTX. In this study, we will determine the risk factors associated with MTX failure. Methods: This ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223cb4b9209bd4268023b4790d2807c7
https://doi.org/10.7759/cureus.18112
https://doi.org/10.7759/cureus.18112
Autor:
Chander, Subhash1,2 (AUTHOR) subhash.chander@mssm.edu, Kumari, Roopa3 (AUTHOR), Wang, Hong Yu1 (AUTHOR), Mohammed, Yaqub Nadeem4 (AUTHOR), Parkash, Om5 (AUTHOR), Lohana, Sindhu6 (AUTHOR), Sorath, FNU7 (AUTHOR), Lohana, Abhi Chand4 (AUTHOR), Sadarat, FNU8 (AUTHOR), Shiwlani, Sheena1 (AUTHOR)
Publikováno v:
BMC Infectious Diseases. 10/8/2024, Vol. 24 Issue 1, p1-16. 16p.
Autor:
Chander, Subhash, Kumari, Roopa, Luhana, Sindhu, Shiwlani, Sheena, Parkash, Om, Sorath, FNU, Wang, Hong Yu, Tan, Sam, Rahaman, Zubair, Mohammed, Yaqub Nadeem, Lohana, Abhi Chand, Sakshi, FNU, Vaish, Esha, Sadarat, FNU
Publikováno v:
BMC Cardiovascular Disorders; 6/25/2024, Vol. 24 Issue 1, p1-17, 17p
Autor:
Chander, Subhash, Parkash, Om, Luhana, Sindhu, Lohana, Abhi Chand, Sadarat, Fnu, Sapna, Fnu, Raja, Fnu, Rahaman, Zubair, Mohammed, Yaqub Nadeem, Shiwlani, Sheena, Kiran, NFN, Wang, Hong Yu, Tan, Sam, Kumari, Roopa
Publikováno v:
BMC Cardiovascular Disorders; 5/30/2024, Vol. 24 Issue 1, p1-20, 20p
Publikováno v:
Blood Weekly; 10/31/2024, p479-479, 1p
Publikováno v:
Clinical Trials Week; 7/15/2024, p603-603, 1p